These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9216859)

  • 1. Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration.
    Iwadate Y; Namba H; Tagawa M; Takenaga K; Sueyoshi K; Sakiyama S
    Oncology; 1997; 54(4):329-34. PubMed ID: 9216859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.
    Parsa AT; Chi JH; Hurley PT; Jeyapalan SA; Bruce JN
    Neurosurgery; 2001 Sep; 49(3):681-8; discussion 688-9. PubMed ID: 11523680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.
    Cool V; Pirotte B; Gérard C; Dargent JL; Baudson N; Levivier M; Goldman S; Hildebrand J; Brotchi J; Velu T
    Hum Gene Ther; 1996 Mar; 7(5):627-35. PubMed ID: 8845388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
    Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging.
    Namba H; Iwadate Y; Tagawa M; Kimura M; Shimizu H; Sato Y; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1996 Oct; 7(15):1847-52. PubMed ID: 8894676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine kinase-mediated killing of rat brain tumors.
    Barba D; Hardin J; Ray J; Gage FH
    J Neurosurg; 1993 Nov; 79(5):729-35. PubMed ID: 8410252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
    Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
    Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
    Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.
    Boviatsis EJ; Park JS; Sena-Esteves M; Kramm CM; Chase M; Efird JT; Wei MX; Breakefield XO; Chiocca EA
    Cancer Res; 1994 Nov; 54(22):5745-51. PubMed ID: 7954393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
    Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
    Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
    Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
    Kramm CM; Rainov NG; Sena-Esteves M; Barnett FH; Chase M; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Oct; 7(16):1989-94. PubMed ID: 8930659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ganciclovir on herpes simplex virus-mediated oncolysis.
    Carroll NM; Chase M; Chiocca EA; Tanabe KK
    J Surg Res; 1997 May; 69(2):413-7. PubMed ID: 9224416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ; Trask TW; Chen SH; Goodman JC; Woo SL; Grossman RG; Shine HD
    J Neurosci Res; 1994 Nov; 39(4):506-11. PubMed ID: 7884826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.